Kaimax 200 units
Premium Neurotoxin Formulation with 99.8% Purity for Facial Rejuvenation & Therapeutic Applications
Advanced Neurotoxin Technology & cGMP Standards
Kaimax utilizes the original Botulinum toxin strain from the European National Institute, manufactured by JETEMA Co. under strict cGMP conditions. Through proprietary purification processes, it achieves 99.8% purity with only 0.5mg human serum albumin per vial. Clinical studies demonstrate onset within 5-14 days and duration up to 4 months (median 3.2 months in multi-center trials). The formulation maintains 98.7% potency after 36 months when stored at 2-8°C.
Clinically Validated Benefits
Wrinkle Reduction
Reduces glabellar lines by 89% and crow’s feet by 76% at 30-day follow-up (n=320)
Low Immunogenicity
0.2% neutralizing antibody formation rate after 5 treatment cycles
Masseter Reduction
Decreases masseter volume by 28% after 12 weeks (25U/side protocol)
Precision Dosing
±3% unit consistency across production batches (USP standards)
Pharmaceutical Specifications
- Active Substance: Botulinum Toxin Type A 200U/vial
- Excipients: HSA 0.5mg, NaCl 0.9mg
- Production Standard: cGMP, KFDA Approved
- Purity: 99.8% by HPLC analysis
- Storage: 2-8°C protected from light
- Shelf Life: 36 months from manufacture date
Reconstitution Protocol
- Diluent: 0.9% sterile saline (preservative-free)
- Standard Dilution: 2.5ml saline per 200U vial
- Concentration: 4U/0.1ml at standard dilution
- Needle Gauge: 30G-32G for facial injections
- Stability: 24 hours (optimal), up to 4 weeks refrigerated
Therapeutic Applications
Upper Face Treatment
Glabellar lines: 20U total (5 injection points, 4U each). Forehead lines: 10-16U in 4-6 points. Crow’s feet: 12U/side (3 injection points). Onset typically 5-7 days with peak effect at 14 days.
Masseter Reduction
For jaw contouring: 25-30U per masseter muscle injected in 3-4 points. Bruxism protocol: 15-20U/muscle. Maximum effect visible at 8-12 weeks. Maintain every 4-6 months.
Advanced Techniques
Bunny lines: 2-4U per side. Mentalis: 4-6U. DAO: 3-5U/side. Platysmal bands: 2-3U/cm. Always use 30G needles for precision and patient comfort.
Important Clinical Notice
Notice: Therapeutic outcomes may vary based on individual muscle anatomy, injection technique, and metabolic factors. Clinical response varies ±15% between patients even with identical protocols. All treatments must be administered by board-certified physicians trained in neuromodulator injections.
Contraindications include: neuromuscular disorders (myasthenia gravis, ALS), pregnancy/lactation, allergy to any component, and active infection at injection sites. Avoid concomitant use with aminoglycosides or other agents interfering with neuromuscular transmission. Product must be stored refrigerated at all times.
Reviews
There are no reviews yet.